TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
VOR

Vor Biopharma Inc

Healthcare · Biotechnology

18.10$ -5.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Vor Biopharma Inc (VOR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 481 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VOR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
223 210 167 142 116 143 109 205 176 464 507 481
164 141 112 90 67 97 65 205 172 458 501 475
45 31 45 76 53 82 50 193 160 396 170 108
160 137 107 86 63 92 60 203 170 455 492 466
48 59 44 44 43 46 43 1,711 2,402 628 657 681
15 16 13 14 14 19 17 59 19 25 16 25
3.7 3.8 4.0 4.1 4.2 4.2 4.3 – 0.3 0.3 0.3 0.3
1.3 0.8 2.3 2.0 1.3 1.5 3.7 0.7 0.9 5.1 1.0 4.0
175 151 123 98 73 97 66 -1,506 -2,225 -164 -150 -200
-314 -340 -371 -399 -426 -457 -489 -2,063 -2,876 -1,153 -1,373 -1,435
3.4 3.4 3.4 3.4 3.4 3.4 6.2 6.3 6.7 9.9 0.4 54

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?